In-Depth Research On:
Sunesis Pharmaceuticals, Inc. (SNSS)

Sign Up Now to Download a Free Research Report on SNSS

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals shares spiked 18.29 percent to close at $4.98 a share Friday. The stock traded between $4.41 and $5.08 on volume 6.04 million shares traded. The company announced that it is scheduled to present at two upcoming conferences; the Leerink Global Healthcare Conference and the 2014 RBC Capital Markets’ Global Healthcare Conference. Shares of Sunesis Pharmaceuticals have are up approximately 5.0 percent year-to-date.

Going forward ... (see research report)


RESEARCH REPORT ON SNSS
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on